J&J seeks to rewrite the script on depression treatment
A survey has found that most patients with depression have little hope of being free of their symptoms, and Johnson & Johnson aims to change that.
Newsletters and Deep Dive digital magazine
A survey has found that most patients with depression have little hope of being free of their symptoms, and Johnson & Johnson aims to change that.
Precision diagnostics enable targeted therapeutics.
Mental disorders account for a significant share of economic cost across EU Member States and the United Kingdom.
Researchers have used a machine learning algorithm to try to work out why Parkinson's disease patients can respond so differently to treatment.
Brian Laird explains a more dynamic, data-driven approach to copay is redefining affordability, creating a new standard for balancing patient support.
Editor's Picks
Newsletters and Deep Dive
digital magazine